ExaMD uses Wearable Devices in a Breast Cancer Observational Study with Daiichi Sankyo
–  Part of Daiichi Sankyo’s Total Care Ecosystem for analyzing physical activity and contributing to new digital services –

ExaMD, a fully owned subsidiary of ExaWizards Inc. (Minato-ku, Tokyo, Representative Director & President: Makoto Haruta, hereinafter ExaWizards) has jointly initiated an observational study targeting early-stage breast cancer patients as part of the Total Care Ecosystem proposed by Daiichi Sankyo Co., Ltd. (Chuo-ku, Tokyo, Representative Director & President: Hiroyuki Okuzawa, hereinafter Daiichi Sankyo). This Total Care Ecosystem clinical study, called “TRACK-BC,” evaluates physical activity through wearable devices. The results of this clinical study, which is rare globally, are attracting much attention, and we are aiming to complete the analysis by the end of FY2025. ExaMD will contribute to new AI digital services utilizing the results of this study.

☑︎Initiative Objectives
This study will use the wearable device “Fitbit®” and a smartphone app to record patient information. This will clarify changes in physical activity associated with chemotherapy in early-stage breast cancer patients, and will evaluate the relationship between changes in physical activity and changes in physical and mental conditions. 100 early-stage breast cancer patients are expected to participate.
Breast cancer has a high incidence rate among women aged 45-54. Tracking decreases in physical activity through this study will contribute to helping women who work while receiving treatment plan work schedules, life events, job allocations, and to secure rest and support systems.

☑︎The Total Care Ecosystem
This initiative is the first solution provided by the collaboration with core partner companies in the Total Care Ecosystem that was announced last year. The Total Care Ecosystem plans to collaborate with multiple industries to expand the system in the health and medical fields, utilizing points of contact with organizations in the ExaWizards Group.

☑︎ExaWizards Group’s Initiatives
This study and future initiatives will allow ExaWizards to plan how to most effectively utilize their AI “exaBase Healthcare Data Platform” to accelerate the use of AI, other assets, and organizational capabilities to provide solutions to patients and consumers.

As a wholly-owned subsidiary of ExaWizards, ExaMD plans, develops, and provides AI services in the health and medical fields. ExaMD is developing Software as a Medical Device (SaMD) for dementia diagnosis through normal conversation, and is building a business foundation and organizational structure to support these devices. We have established a system that can develop and operate new services in the health and medical fields with high QCD (Quality, Cost, Delivery) through these business foundations. We will continue cross-industry collaborations to solve social issues related to health and medical care, including finance, insurance, consumer goods, and transportation, and to form an ecosystem unique to ExaMD.

☑︎About the Total Care Ecosystem
Daiichi Sankyo is developing the Total Care Ecosystem to solve the problems of patients and individuals for their well-being. The Total Care Ecosystem will create and provide holistic solutions ranging from health promotions to prevention, treatment, and post-treatment care, through collaboration with organizations in health and medical fields, data providers, and IT companies.

[Daiichi Sankyo Company Profile]
Company Name: Daiichi Sankyo Co., Ltd.
Location: 5-1, Nihonbashi 3-chome, Chuo-ku, Tokyo
Established: September 28, 2005
Representative: Hiroyuki Okuzawa, Representative Director & President
Business: Research, development, manufacturing, and sales of pharmaceuticals, etc.
URL: https://www.daiichisankyo.co.jp/

【ExaMD Corporate profile】
Company name: ExaMD Inc.
Location: 4-2-8 Shibaura, Minato-ku, Tokyo, 5F, Sumitomo Realty & Development Mita Twin Building East
Established: February 1, 2024 (scheduled) 
Representative: Koji Hazama, Representative Director
Business: Planning, development, sales, and alliance of products and services using multi-modal AI technology to solve social issues related to healthcare 
URL: https://examd.com/

【ExaWizards Corporate profile】
Company name: ExaWizards Inc.
Location: 4-2-8 Shibaura, Minato-ku, Tokyo, 5F, Sumitomo Realty & Development Mita Twin Building East
Established: February 2016
Representative: Makoto Haruta, Representative Director & President
Business: Industrial innovation and resolution of social issues via AI service development
URL: https://exawizards.com/

*ExaWizards will relocate from 1-9-2 Higashi-Shinbashi, Minato-ku, Tokyo to 4-2-8 Shibaura, Minato-ku, Tokyo, effective March 18, 2024. The locations of both companies will be the same.

<Public relations>
Public Relations , ExaWizards Inc. Email: publicrelations@exwzd.com